| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 177.06 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Familial hypercholesterolaemia is an autosomal
dominant disorder of lipid metabolism characterized by elevated levels of LDL-C and increased cardiovascular risk. Although the disorder can be
diagnosed based on established clinical criteria, only
the genetic diagnosis confirms the clinical suspicion. There are three main genes associated with
familial hypercholesterolaemia: LDL receptor
(LDLR), responsible for more than 90% of the cases,
apolipoprotein B (APOB), responsible for 5–10% of
the cases and Proprotein Convertase Subtilisin/
Kexin Type 9 (PCSK9), responsible for up to 3% of
the cases. However, reporting of situations where
there is an overlap of the familial hypercholesterolaemia phenotype and other conditions is now
growing. (...)
Description
Editorial
Keywords
Ester Storage Disease Apo-B mutations Identification Diagnosis Variants STAP1 Familial hypercholesterolaemia Doenças Cardio e Cérebro-vasculares Hpercolesterolemia Familiar
Pedagogical Context
Citation
Curr Opin Lipidol. 2019 Apr;30(2):148-150. doi: 10.1097/MOL.0000000000000584.
Publisher
Wolters Kluwer Health
